Buckle up, CG Oncology (NASDAQ: CGON) investors, because things are about to get bumpy...in the best way possible! Today, Wall...
Overweight rating
Is CG Oncology (CGON) a buy? See why Morgan Stanley’s bullish “Overweight” rating has investors buzzing.
